1 - Research experience and ability
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | |
|---|---|
Name |
Newcastle-CCLG - Newcastle Children's Cancer and Leukaemia Pharmacology Studies Group |
| Number of completed trials | 12 |
| Number of ongoing trials | 7 |
| Total number of participants actually recruited each year | 0 |
| Proportion of eligible participants actually recruited each year | |
| Describe way of screening and participant recruitment | Children who are receiving specific chemotherapeutics as part of their routine treatment are generally eligible to participate in the majority of our studies. These patients are identified by clinicians or research nurses and patient and/or parent consent must be obtained prior to study recruitment and participation. |
| Total number of collaborating centres | 18 |
| Academic investigator initiated studies | |
| Number of ongoing and completed clinical trials. Absolute number | 19 |
| Number of ongoing and completed clinical trials. Proportion of all studies | 100% |
| Number of paediatric specialties covered by paediatric trials] | 1 |
| Number of paediatric conditions covered by paediatric trials] | |
| Number of other ongoing research studies programs] | |
| Proportion of academic initiated studies | |
| Proportion of budget | |
| Number of registered study participants. All studies |
0 |
| Number of ongoing and completed trials | |
| Number of paediatric specialties covered by paediatric trials | |
| Number of paediatric conditions covered by paediatric trialss | |
| Number of registered study participants all studies |